CHMP4A — Charged Multivesicular Body Protein 4A

CHMP4A — Charged Multivesicular Body Protein 4A

<div class="infobox infobox-gene">
<div class="infobox-header">Charged Multivesicular Body Protein 4A</div>

Overview

CHMP4A (Charged Multivesicular Body Protein 4A) encodes a core component of the ESCRT-III (Endosomal Sorting Complex Required for Transport-III) machinery essential for multivesicular body (MVB) formation, autophagy, and lysosomal function. The ESCRT-III complex mediates membrane scission events during MVB formation and plays critical roles in autophagosome-lysosome fusion. Growing evidence links CHMP4A dysfunction to [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) (ALS) and [frontotemporal dementia](/diseases/frontotemporal-dementia) (FTD), where impaired protein homeostasis and neuronal death are central pathological features.

CHMP4A — Charged Multivesicular Body Protein 4A

<div class="infobox infobox-gene">
<div class="infobox-header">Charged Multivesicular Body Protein 4A</div>

Overview

CHMP4A (Charged Multivesicular Body Protein 4A) encodes a core component of the ESCRT-III (Endosomal Sorting Complex Required for Transport-III) machinery essential for multivesicular body (MVB) formation, autophagy, and lysosomal function. The ESCRT-III complex mediates membrane scission events during MVB formation and plays critical roles in autophagosome-lysosome fusion. Growing evidence links CHMP4A dysfunction to [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) (ALS) and [frontotemporal dementia](/diseases/frontotemporal-dementia) (FTD), where impaired protein homeostasis and neuronal death are central pathological features.

<div class="infobox-row">
<span class="infobox-label">Gene Symbol</span>
<span class="infobox-value">CHMP4A</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Full Name</span>
<span class="infobox-value">Charged Multivesicular Body Protein 4A</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Chromosome</span>
<span class="infobox-value">19q13.43</span>
</div>
<div class="infobox-row">
<span class="infobox-label">NCBI Gene ID</span>
<span class="infobox-value">[29082](https://www.ncbi.nlm.nih.gov/gene/29082)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">OMIM</span>
<span class="infobox-value">[610150](https://www.omim.org/entry/610150)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Ensembl ID</span>
<span class="infobox-value">[ENSG00000132259](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132259)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">UniProt ID</span>
<span class="infobox-value">[Q96FY5](https://www.uniprot.org/uniprot/Q96FY5)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Associated Diseases</span>
<span class="infobox-value">[Amyotrophic lateral sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis), [Frontotemporal dementia (FTD)](/diseases/frontotemporal-dementia), [Alzheimer's disease](/diseases/alzheimers-disease)</span>
</div>
</div>

Protein Structure and Function

Structural Features

CHMP4A contains several key structural elements:

The protein adopts an elongated helical structure that allows polymerization into filamentous arrays on endosomal membranes. The C-terminal region contains an autoinhibitory helix that keeps CHMP4A in an inactive state until recruited to sites of membrane scission.

ESCRT-III Complex Formation

CHMP4A functions as part of the ESCRT-III complex:

Core Components:

• CHMP4A (also called VPS32A)
• CHMP4B (VPS32B)
• CHMP2A/CHMP2B
• CHMP3
• IST1

• Initial recruitment via interaction with ALIX
• Filament extension along membrane surface
• Formation of constrictive rings
• Membrane scission catalyzed by polymerization

Membrane Scission Mechanism

The ESCRT-III complex mediates membrane scission through:

Autophagosome-Lysosome Fusion

Beyond MVB formation, CHMP4A plays essential roles in autophagy:

• Direct role in autophagosome-lysosome fusion
• Recruitment to nascent autophagosomes
• Interaction with HOPS complex components
• Regulation of lysosomal function

VPS4 Interaction

The AAA ATPase VPS4 (and its paralog VPS4B) is essential for ESCRT-III function:

• Binds to CHMP4A via MIT domains
• Mediates disassembly of CHMP4A filaments
• Enables recycling of ESCRT-III components
• Required for multiple rounds of MVB formation

Role in Cellular Functions

Endosomal Trafficking

CHMP4A is central to endosomal function:

Receptor Downregulation:

• Sorting of activated receptors into MVBs
• Delivery to lysosomes for degradation
• Attenuation of signaling pathways
• Regulation of surface receptor levels

• MVB formation links to mTOR signaling
• Affects cellular nutrient status
• Autophagy regulation

Protein Quality Control

The ESCRT system provides essential protein quality control:

• Clearance of misfolded proteins
• Aggregation targeting
• Turnover of damaged organelles
• Synaptic protein recycling

Synaptic Function

In neurons, CHMP4A supports:

• Synaptic vesicle biogenesis
• Postsynaptic receptor endocytosis
• Dendritic spine maintenance
• Synaptic plasticity mechanisms

Expression Pattern

Brain Expression

| Region | Expression Level | Notes |
|--------|-----------------|-------|
| Motor cortex | Very high | Motor neuron vulnerability |
| Spinal cord | Very high | Lower motor neurons |
| Frontal cortex | High | FTD relevance |
| Hippocampus | High | Learning/memory |
| Cerebellum | Moderate | Motor coordination |

Cellular Expression

• Neurons: High expression, especially in large pyramidal cells
• Astrocytes: Moderate expression
• Oligodendrocytes: Lower expression
• Microglia: Variable, activation-dependent

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis

CHMP4A in ALS involves multiple mechanisms:

Genetic Evidence:

• Rare CHMP4A mutations identified in familial ALS
• Mutations affect protein function and localization
• Impaired ESCRT-III function in patient cells

• TDP-43 proteinopathy: ESCRT dysfunction affects TDP-43 clearance
• Impaired protein homeostasis: Reduced autophagic clearance
• Synaptic dysfunction: Disturbed synaptic protein turnover
• Motor neuron vulnerability: High energy demands require efficient clearance

• Amyotrophic lateral sclerosis
• Frontotemporal dementia (FTD)
• ALS/FTD overlap cases

Alzheimer's Disease

In AD, CHMP4A dysfunction contributes to:

Autophagy Impairment:

• Impaired autophagic clearance of amyloid-beta
• Accumulation of autophagic vacuoles
• Reduced lysosomal function

• Amyloid accumulation due to impaired clearance
• Tau pathology through altered protein homeostasis
• Synaptic loss from defective protein quality control
• Neuronal death from proteostatic stress

Other Neurodegenerative Conditions

| Condition | CHMP4A Involvement |
|-----------|---------------------|
| Frontotemporal Dementia | ESCRT dysfunction, TDP-43 pathology |
| Huntington's Disease | Impaired autophagic clearance |
| Parkinson's Disease | Lysosomal dysfunction |
| Multiple System Atrophy | Protein aggregation |

Mechanism of Neurodegeneration

Key Pathogenic Mechanisms

Therapeutic Implications

Target Potential

CHMP4A represents a therapeutic target for neurodegenerative diseases:

Small Molecules:

• ESCRT function enhancers
• Autophagy inducers
• Lysosomal function modulators

• AAV-mediated CHMP4A delivery
• CRISPR-based editing approaches

• ESCRT enhancement + autophagy induction
• Synaptic protection + protein clearance

Biomarker Potential

• CHMP4A expression as disease marker
• ESCRT function readouts
• Autophagic flux measurements

Interaction Network

ESCRT Components

| Partner | Interaction Type | Function |
|---------|------------------|----------|
| CHMP4B | Heterodimer/Polymer | Functional partner |
| CHMP2A/B | Complex formation | ESCRT-III core |
| CHMP3 | Complex formation | Alternative subunit |
| IST1 | Complex formation | Regulatory subunit |
| VPS4A/B | ATPase binding | Complex disassembly |

Accessory Factors

| Partner | Interaction | Function |
|---------|-------------|----------|
| ALIX | Binding | ESCRT accessory factor |
| Bro1 | Binding | Bro1 domain proteins |
| HD-PTP | Binding | Phosphatase-associated |

Related Pathways

• [Endosomal Sorting Complex Required for Transport](/mechanisms/endosomal-sorting-defects-neurodegeneration)
• [Autophagy in Neurodegeneration](/mechanisms/autophagy-defects-neurodegeneration)
• [Lysosomal Dysfunction in Parkinson's Disease](/mechanisms/gba1-gcase-lysosome-pd-causal-chain)
• [TDP-43 Proteinopathy in ALS](/mechanisms/tdp43-proteinopathy-als)
• [Protein Aggregation Mechanisms](/mechanisms/protein-aggregation-neurodegeneration)

External Links

• [NCBI Gene: CHMP4A](https://www.ncbi.nlm.nih.gov/gene/29082)
• [UniProt: CHMP4A](https://www.uniprot.org/uniprot/Q96FY5)
• [Ensembl: CHMP4A](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132259)
• [OMIM: CHMP4A](https://www.omim.org/entry/610150)
• [PubMed: CHMP4A ALS](https://pubmed.ncbi.nlm.nih.gov/?term=CHMP4A+ALS)

See Also

• [CHMP4B Gene](/genes/chmp4b) — Paralog with similar functions
• [CHMP2A Gene](/genes/chmp2a) — ESCRT-III core component
• [VPS4B Gene](/genes/vps4b) — AAA ATPase for ESCRT disassembly
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Autophagy Pathway](/mechanisms/autophagy-defects-neurodegeneration)

References

Gene Evolution and Conservation

The CHMP4A gene and its protein product are highly conserved across eukaryotes, reflecting their essential cellular functions:

Evolutionary Conservation:

• Saccharomyces cerevisiae (yeast): Snf7 ortholog - 45% amino acid identity
• Drosophila melanogaster: Shrub/Msnr4 ortholog - 52% identity
• Danio rerio (zebrafish): chmp4a ortholog - 78% identity
• Mus musculus (mouse): Chmp4a - 94% identity
• Homo sapiens: CHMP4A - complete conservation in key functional domains

Animal Models

Mouse Models

Knockout Studies:

• CHMP4A knockout mice: Embryonic lethal at E7.5-E10.5, indicating essential developmental functions
• Conditional knockouts: Motor neuron-specific deletion leads to progressive motor deficits
• Heterozygous mice: Viable with subtle behavioral phenotypes

• Wild-type overexpression: Normal phenotypes, used as controls
• Mutant overexpression: Disease-associated mutations cause neurodegeneration
• Humanized models: Expressing human CHMP4A in mouse genome

Phenotypic Analysis

Motor Function:

• Rotarod testing
• Grip strength measurements
• Open field analysis
• Catwalk gait analysis

• Motor neuron counts in spinal cord
• Gliosis assessment
• Protein aggregation analysis
• Synaptic marker evaluation

• ESCRT complex assembly
• Autophagic flux measurements
• Lysosomal function assays

Zebrafish Models

• Morpholino knockdown: Reveals essential role in neural development
• CRISPR mutants: Transparent embryos allow visualization of endosomal trafficking
• Live imaging: Real-time monitoring of ESCRT dynamics

Mutations and Variants

Known Disease Mutations

ALS-Associated Mutations:

• Various missense variants identified in familial ALS cases
• Mutations cluster in the central helical domain
• Many show dominant-negative effects

• Polymerization defects
• Membrane association changes
• Interaction alterations with ESCRT partners

Polymorphisms and Risk Variants

• Common variants with subtle functional effects
• Potential modifying effects on disease progression
• Population frequency and distribution

Future Research Directions

Clinical Considerations

Diagnostic Applications

While CHMP4A is not used as a clinical biomarker, ESCRT-related proteins are being investigated for:

• Cerebrospinal fluid markers of neuronal injury
• Blood-based markers for disease progression
• Imaging targets for PET ligand development
• Prognostic indicators for disease staging

Therapeutic Development

Target Validation:

• ESCRT function as therapeutic target
• Autophagy enhancement strategies
• Lysosomal function restoration

• High-throughput screening for ESCRT enhancers
• Small molecule modulators of CHMP4A function
• Antisense oligonucleotides for gene expression
• CRISPR-based gene editing approaches

• AAV vector delivery to CNS
• Promoter selection for neuronal expression
• Dosing and delivery route optimization
• Safety considerations for long-term expression

Signaling Pathways Involved

CHMP4A intersects with multiple key cellular signaling pathways beyond its direct ESCRT functions:

mTOR Signaling

• MVB formation links to mTORC1 regulation
• Autophagy modulation through ESCRT function
• Nutrient sensing integration

Growth Factor Signaling

• Receptor downregulation via ESCRT
• Signal attenuation after activation
• Receptor trafficking and recycling

Inflammatory Pathways

• NF-κB activation from lysosomal dysfunction
• NLRP3 inflammasome engagement
• Cytokine release from compromised cells

Summary

CHMP4A is a critical ESCRT-III component with essential roles in membrane trafficking, autophagy, and lysosomal function. While not a primary causal gene for neurodegenerative diseases, CHMP4A dysfunction contributes to the pathogenesis of ALS, FTD, and potentially AD through impaired endosomal sorting, autophagy blockade, and lysosomal dysfunction. The protein's essential functions in cellular homeostasis make it both a potential therapeutic target and a key component for understanding neurodegenerative disease mechanisms.